Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase NA 1

Status

Recruiting 7Unknown 6Terminated 6Completed 6Not yet recruiting 4

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 6

Conditions

Leukemia, Myeloid, Acute 6Recurrence 1Leukemia 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Drug Therapy 219Cyclophosphamide 219Paclitaxel 205apatinib 201Bevacizumab 196camrelizumab 190Fluorouracil 188sintilimab 133Irinotecan 125Blood Specimen Collection 125Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 112Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 102Surveys and Questionnaires 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × OTHER × Homoharringtonine × Clear all
NCT05805072 2023-05-06

Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

The First Affiliated Hospital of Soochow University

Phase NA Unknown
20 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04248595 2022-09-08

Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

Zhongda Hospital

Phase 2 Unknown
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05457361 2022-07-14

VAH Versus VA for Salvage Therapy of R/R-AML

Nanfang Hospital, Southern Medical University

Phase 3 Unknown
162 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04722952 2021-12-03

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine,Cytarabine, G-CSF for Refractory or Relapsed AML

The First Affiliated Hospital of Soochow University

Phase 3 Unknown
30 enrolled
Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT03135054 2020-12-10

Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD

The University of Hong Kong

Phase 2 Unknown
40 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04083911 2019-09-10

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

The First Affiliated Hospital of Soochow University

Phase 3 Unknown
50 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡